Combunox Forest Laboratories, Inc. - Treatment for Moderate to Severe Pain

Combunox is a fixed-dose combination of the opioid oxycodone HCl (5 mg) and the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen (400 mg) indicated for the short-term management of acute, moderate to severe pain. Forest expects to make Combunox available in the U.S. early next year.

Posted: November 2004

Combunox (ibuprofen and oxycodone hydrochloride) FDA Approval History

View comments

Hide
(web2)